맞춤형 기능성 영양 시장 예측(-2034년) : 제품 유형, 건강 효과, 기술, 유통 채널, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Personalized Functional Nutrition Market is accounted for $12.7 billion in 2026 and is expected to reach $28.8 billion by 2034 growing at a CAGR of 14.6% during the forecast period. Personalized functional nutrition refers to dietary products, supplements, and nutritional interventions that are formulated, recommended, or customized based on individual biological data including genetic profiles, microbiome composition, biomarker levels, and lifestyle parameters to optimize health outcomes and address specific physiological needs. These products leverage artificial intelligence algorithms, digital health platforms, and advanced analytical technologies to translate personal health data into targeted nutrient formulations, meal plans, and supplement regimens that account for individual metabolic variations, nutrient absorption efficiencies, and disease risk profiles rather than applying generic population-based dietary guidelines.

Market Dynamics:

Driver:

Digital Health Data Proliferation

The exponential growth in consumer-generated health data from wearable fitness trackers, at-home genetic testing kits, microbiome analysis services, and continuous glucose monitors is creating unprecedented opportunities to develop data-driven personalized nutrition products. Consumers increasingly expect health recommendations tailored to their unique biological profiles, while integration between digital health platforms and e-commerce systems enables seamless translation of biomarker data into personalized supplement subscriptions and functional food recommendations that drive recurring revenue models.

Restraint:

Clinical Validation Deficits

The limited body of large-scale randomized controlled trials demonstrating superior health outcomes from personalized nutrition interventions compared to standard dietary recommendations creates skepticism among healthcare providers and regulatory authorities regarding product efficacy claims. The complexity of gene-nutrient interactions and the influence of environmental variables on microbiome composition make it difficult to establish consistent causal relationships between personalized recommendations and measurable health improvements, which constrains medical professional endorsement and insurance reimbursement coverage.

Opportunity:

Chronic Disease Management Integration

Rising global prevalence of diabetes, cardiovascular disease, and metabolic syndrome is creating substantial demand for nutrition interventions that complement pharmaceutical treatments by addressing individual dietary risk factors and nutrient deficiencies identified through biomarker testing. Healthcare systems and insurance providers seeking to reduce long-term treatment costs are increasingly evaluating personalized nutrition programs for covered preventive care benefits, while pharmaceutical companies are exploring companion nutrition products that enhance drug efficacy through targeted micronutrient support.

Threat:

Data Privacy Regulatory Risk

The collection and analysis of sensitive genetic, microbiome, and biomarker data for personalized nutrition purposes exposes companies to evolving data privacy regulations including GDPR in Europe and emerging genetic information protection laws that impose strict consent, storage, and sharing requirements. Consumer concerns regarding the potential misuse of biological data by insurance companies, employers, or third parties can limit willingness to participate in personalized nutrition programs, while regulatory enforcement actions against inadequate data protection practices can result in substantial fines and reputational damage.

Covid-19 Impact:

COVID-19 accelerated adoption of digital health services and remote wellness monitoring that provided foundational infrastructure for personalized nutrition platform growth, as consumers became accustomed to at-home health testing and virtual consultations. Post-pandemic emphasis on immune health and metabolic resilience has strengthened demand for personalized supplements targeting individual immune profiles and inflammation markers, while healthcare system digitization investments have improved interoperability between electronic health records and nutrition recommendation platforms.

The personalized dietary supplements segment is expected to be the largest during the forecast period

The personalized dietary supplements segment is expected to account for the largest market share during the forecast period, due to supplements representing the most accessible and commercially mature format for delivering personalized nutrition through direct-to-consumer subscription models and retail customization services. The established global dietary supplement market provides a familiar consumer entry point for personalized products, while the relatively straightforward manufacturing of customized capsule and powder formulations enables rapid scaling of personalized supplement businesses compared to complex functional food production.

The cognitive health segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive health segment is predicted to witness the highest growth rate, driven by aging populations across developed markets and increasing scientific understanding of the relationships between specific nutrients, gut microbiome composition, and cognitive function. Consumer anxiety regarding age-related cognitive decline and the rising diagnosis rates of neurodegenerative conditions are fueling investment in personalized nootropic and brain health formulations, while digital cognitive assessment tools enable objective tracking of intervention efficacy that supports repeat purchase behavior.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the United States possessing the most advanced direct-to-consumer health testing ecosystem with established consumer familiarity with genetic testing, microbiome analysis, and biomarker monitoring services. Leading personalized nutrition companies including Viome Life Sciences, Inc. and Thorne HealthTech, Inc. are headquartered in North America and maintain extensive digital health platform user bases, while venture capital investment in precision health startups continues to outpace other regions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding digital health adoption across China, Japan, and South Korea combined with government initiatives promoting preventive healthcare and healthy aging strategies. The region's large aging populations and rising chronic disease burden create strong structural demand for personalized preventive nutrition, while advanced mobile payment infrastructure and e-commerce penetration support seamless integration of health data collection with personalized product purchasing and delivery systems.

Key players in the market

Some of the key players in Personalized Functional Nutrition Market include Nestle Health Science, Herbalife Ltd., Abbott Laboratories, Amway Corporation, DSM-Firmenich AG, Danone S.A., Bayer AG, Haleon plc, Thorne HealthTech, Inc., Bioniq Health-Tech Solutions Ltd., Viome Life Sciences, Inc., Zoe Limited, Persona Nutrition, Care/of, InsideTracker, Wellory and DayTwo Ltd..

Key Developments:

In June 2026, Nestle Health Science launched an AI-powered personalized nutrition platform integrating continuous glucose monitor data with microbiome analysis to generate real-time supplement recommendations for metabolic health optimization.

In May 2026, Viome Life Sciences, Inc. expanded its personalized supplement subscription service to European markets, leveraging its RNA-based microbiome testing technology to deliver customized formulations across gut health and immune function categories.

In April 2026, Abbott Laboratories secured FDA clearance for its biomarker-based personalized nutrition diagnostic system, enabling healthcare providers to prescribe targeted nutritional interventions based on individual metabolic panel results.

Product Types Covered:

• Personalized Dietary Supplements
• Personalized Functional Foods
• Personalized Functional Beverages
• Personalized Nutrition Powders
• Personalized Nutrition Bars
• Personalized Meal Replacements
• Other Product Type

Health Benefits Covered:

• Immune Health
• Gut Health
• Weight Management
• Cognitive Health
• Heart Health
• Sports Nutrition
• Healthy Aging

Technologies Covered:

• Artificial Intelligence-Based Nutrition
• Genetic Testing-Based Nutrition
• Microbiome Analysis
• Wearable Device Integration
• Digital Nutrition Platforms
• Biomarker-Based Nutrition Planning

Distribution Channels Covered:

• Online Platforms
• Direct-to-Consumer
• Pharmacies
• Supermarkets and Hypermarkets
• Specialty Nutrition Stores
• Healthcare Providers

Applications Covered:

• Preventive Healthcare
• Clinical Nutrition
• Sports and Fitness
• Women's Health
• Men's Health
• Healthy Lifestyle Management

End Users Covered:

• Adults
• Children
• Senior Citizens
• Athletes
• Patients with Chronic Conditions
• Health-Conscious Consumers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Personalized Functional Nutrition Market, By Product Type

• 5.1 Personalized Dietary Supplements
• 5.2 Personalized Functional Foods
• 5.3 Personalized Functional Beverages
• 5.4 Personalized Nutrition Powders
• 5.5 Personalized Nutrition Bars
• 5.6 Personalized Meal Replacements
• 5.7 Other Product Type

6 Global Personalized Functional Nutrition Market, By Health Benefit

• 6.1 Immune Health
• 6.2 Gut Health
• 6.3 Weight Management
• 6.4 Cognitive Health
• 6.5 Heart Health
• 6.6 Sports Nutrition
• 6.7 Healthy Aging

7 Global Personalized Functional Nutrition Market, By Technology

• 7.1 Artificial Intelligence-Based Nutrition
• 7.2 Genetic Testing-Based Nutrition
• 7.3 Microbiome Analysis
• 7.4 Wearable Device Integration
• 7.5 Digital Nutrition Platforms
• 7.6 Biomarker-Based Nutrition Planning

8 Global Personalized Functional Nutrition Market, By Distribution Channel

• 8.1 Online Platforms
• 8.2 Direct-to-Consumer
• 8.3 Pharmacies
• 8.4 Supermarkets and Hypermarkets
• 8.5 Specialty Nutrition Stores
• 8.6 Healthcare Providers

9 Global Personalized Functional Nutrition Market, By Application

• 9.1 Preventive Healthcare
• 9.2 Clinical Nutrition
• 9.3 Sports and Fitness
• 9.4 Women's Health
• 9.5 Men's Health
• 9.6 Healthy Lifestyle Management

10 Global Personalized Functional Nutrition Market, By End User

• 10.1 Adults
• 10.2 Children
• 10.3 Senior Citizens
• 10.4 Athletes
• 10.5 Patients with Chronic Conditions
• 10.6 Health-Conscious Consumers

11 Global Personalized Functional Nutrition Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Nestle Health Science
• 14.2 Herbalife Ltd.
• 14.3 Abbott Laboratories
• 14.4 Amway Corporation
• 14.5 DSM-Firmenich AG
• 14.6 Danone S.A.
• 14.7 Bayer AG
• 14.8 Haleon plc
• 14.9 Thorne HealthTech, Inc.
• 14.10 Bioniq Health-Tech Solutions Ltd.
• 14.11 Viome Life Sciences, Inc.
• 14.12 Zoe Limited
• 14.13 Persona Nutrition
• 14.14 Care/of
• 14.15 InsideTracker
• 14.16 Wellory
• 14.17 DayTwo Ltd.